Annual Accounts Receivable
$974.80 K
+$745.00 K+324.19%
December 31, 2022
Summary
- As of February 10, 2025, CYAD annual accounts receivable is $974.80 thousand, with the most recent change of +$745.00 thousand (+324.19%) on December 31, 2022.
- During the last 3 years, CYAD annual accounts receivable has risen by +$800.10 thousand (+457.99%).
Performance
CYAD Accounts Receivable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Quarterly Accounts Receivable
$486.80 K
-$554.50 K-53.25%
June 30, 2022
Summary
- As of February 10, 2025, CYAD quarterly accounts receivable is $486.80 thousand, with the most recent change of -$554.50 thousand (-53.25%) on June 30, 2022.
- Over the past year, CYAD quarterly accounts receivable has increased by +$252.40 thousand (+107.68%).
Performance
CYAD Quarterly Accounts Receivable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Accounts Receivable Formula
Accounts Receivable = Total Credit Sales − Amount Collected from Credit Sales
CYAD Accounts Receivable Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +324.2% | +107.7% |
| 3 y3 years | +458.0% | - |
| 5 y5 years | +902.9% | -67.7% |
CYAD Accounts Receivable Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | -76.4% | -53.3% | -52.8% |
| 5 y | 5-year | at high | -82.1% | -53.3% | -64.1% |
| alltime | all time | at high | -96.1% | -68.0% | -92.3% |
Celyad Oncology SA Accounts Receivable History
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2022 | $974.80 K(+324.2%) | - |
| Jun 2022 | - | $486.80 K(-53.3%) |
| Mar 2022 | - | $1.04 M(+353.1%) |
| Dec 2021 | $229.80 K(+13.3%) | $229.80 K(-65.5%) |
| Sep 2021 | - | $665.80 K(+184.0%) |
| Jun 2021 | - | $234.40 K(-66.1%) |
| Mar 2021 | - | $691.70 K(+240.9%) |
| Dec 2020 | $202.90 K(+16.1%) | $202.90 K(-60.0%) |
| Jun 2020 | - | $507.20 K(+190.3%) |
| Dec 2019 | $174.70 K(-44.9%) | $174.70 K(-44.9%) |
| Dec 2018 | $316.90 K(+226.0%) | $316.90 K(+1.1%) |
| Jun 2018 | - | $313.30 K(+222.3%) |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2017 | $97.20 K(+70.2%) | $97.20 K(-93.6%) |
| Jun 2017 | - | $1.51 M(+2540.5%) |
| Dec 2016 | $57.10 K(-15.8%) | $57.10 K(-96.2%) |
| Jun 2016 | - | $1.52 M(+2142.8%) |
| Dec 2015 | $67.80 K(+79.8%) | $67.80 K(-91.8%) |
| Jun 2015 | - | $822.10 K(+2080.6%) |
| Dec 2014 | $37.70 K(-81.7%) | $37.70 K(-77.9%) |
| Jun 2014 | - | $170.50 K(-17.3%) |
| Dec 2013 | $206.20 K(-28.1%) | $206.20 K(-47.8%) |
| Jun 2013 | - | $394.90 K(+37.7%) |
| Dec 2012 | $286.70 K(+27.3%) | $286.70 K |
| Dec 2011 | $225.30 K | - |
FAQ
- What is Celyad Oncology SA annual accounts receivable?
- What is the all time high annual accounts receivable for Celyad Oncology SA?
- What is Celyad Oncology SA annual accounts receivable year-on-year change?
- What is Celyad Oncology SA quarterly accounts receivable?
- What is the all time high quarterly accounts receivable for Celyad Oncology SA?
- What is Celyad Oncology SA quarterly accounts receivable year-on-year change?
What is Celyad Oncology SA annual accounts receivable?
The current annual accounts receivable of CYAD is $974.80 K
What is the all time high annual accounts receivable for Celyad Oncology SA?
Celyad Oncology SA all-time high annual accounts receivable is $974.80 K
What is Celyad Oncology SA annual accounts receivable year-on-year change?
Over the past year, CYAD annual accounts receivable has changed by +$745.00 K (+324.19%)
What is Celyad Oncology SA quarterly accounts receivable?
The current quarterly accounts receivable of CYAD is $486.80 K
What is the all time high quarterly accounts receivable for Celyad Oncology SA?
Celyad Oncology SA all-time high quarterly accounts receivable is $1.52 M
What is Celyad Oncology SA quarterly accounts receivable year-on-year change?
Over the past year, CYAD quarterly accounts receivable has changed by +$252.40 K (+107.68%)